508 related articles for article (PubMed ID: 18343246)
1. Comparison of the effects of doxazosin and atenolol on target organ damage in adults with type 2 diabetes mellitus and hypertension in the CARDHIAC study: a 9-month, prospective, randomized, open-label, blinded-evaluation trial.
Barrios V; Escobar C; Tomás JP; Calderon A; Echarri R
Clin Ther; 2008 Jan; 30(1):98-107. PubMed ID: 18343246
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the effects of losartan and atenolol on common carotid artery intima-media thickness in patients with hypertension: results of a 2-year, double-blind, randomized, controlled study.
Ludwig M; Stapff M; Ribeiro A; Fritschka E; Tholl U; Smith RD; Stumpe KO
Clin Ther; 2002 Jul; 24(7):1175-93. PubMed ID: 12182261
[TBL] [Abstract][Full Text] [Related]
3. Irbesartan reduces common carotid artery intima-media thickness in hypertensive patients when compared with atenolol: the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) study.
Mörtsell D; Malmqvist K; Held C; Kahan T
J Intern Med; 2007 May; 261(5):472-9. PubMed ID: 17444886
[TBL] [Abstract][Full Text] [Related]
4. Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial.
Devereux RB; Dahlöf B; Gerdts E; Boman K; Nieminen MS; Papademetriou V; Rokkedal J; Harris KE; Edelman JM; Wachtell K
Circulation; 2004 Sep; 110(11):1456-62. PubMed ID: 15326072
[TBL] [Abstract][Full Text] [Related]
5. Effects of losartan and atenolol on left ventricular mass and neurohormonal profile in patients with essential hypertension and left ventricular hypertrophy.
Dahlof B; Zanchetti A; Diez J; Nicholls MG; Yu CM; Barrios V; Aurup P; Smith RD; Johansson M;
J Hypertens; 2002 Sep; 20(9):1855-64. PubMed ID: 12195129
[TBL] [Abstract][Full Text] [Related]
6. Arterial wave reflection during antihypertensive therapy with barnidipine: a 6-month, open-label study using an integrated cardiovascular ultrasound approach in patients with newly diagnosed hypertension.
Palombo C; Malshi E; Morizzo C; Rakebrandt F; Corretti V; Santini F; Fraser AG; Kozakova M
Clin Ther; 2009 Dec; 31(12):2873-85. PubMed ID: 20110026
[TBL] [Abstract][Full Text] [Related]
7. Cardiac structural and functional changes during long-term antihypertensive treatment with lacidipine and atenolol in the European Lacidipine Study on Atherosclerosis (ELSA).
Agabiti-Rosei E; Trimarco B; Muiesan ML; Reid J; Salvetti A; Tang R; Hennig M; Baurecht H; Parati G; Mancia G; Zanchetti A;
J Hypertens; 2005 May; 23(5):1091-8. PubMed ID: 15834297
[TBL] [Abstract][Full Text] [Related]
8. Importance of blood pressure control in left ventricular mass regression.
Miller AB; Reichek N; St John Sutton M; Iyengar M; Henderson LS; Tarka EA; Bakris GL
J Am Soc Hypertens; 2010; 4(6):302-10. PubMed ID: 20980215
[TBL] [Abstract][Full Text] [Related]
9. Prazosin GITS vs atenolol in patients with hypertension and normal lipid profile: a randomized, controlled multicenter study. Hyderabad Hypertension Study Group.
Joglekar SJ; Jaguste V; Nanivadekar AS
J Assoc Physicians India; 1998; Suppl 1():41-51. PubMed ID: 11233386
[TBL] [Abstract][Full Text] [Related]
10. Effects of candesartan cilexetil on carotid remodeling in hypertensive diabetic patients: the MITEC study.
Baguet JP; Asmar R; Valensi P; Nisse-Durgeat S; Mallion JM
Vasc Health Risk Manag; 2009; 5(1):175-83. PubMed ID: 19436670
[TBL] [Abstract][Full Text] [Related]
11. Multicenter, double-blind comparison of doxazosin and atenolol in patients with mild to moderate hypertension.
Ott P; Storm TL; Krusell LR; Jensen H; Badskjaer J; Faergeman O
Am J Cardiol; 1987 May; 59(14):73G-77G. PubMed ID: 2884856
[TBL] [Abstract][Full Text] [Related]
12. Lisinopril improves endothelial dysfunction in hypertensive NIDDM subjects with diabetic nephropathy.
Nielsen FS; Rossing P; Gall MA; Smidt UM; Chen JW; Sato A; Parving HH
Scand J Clin Lab Invest; 1997 Aug; 57(5):427-34. PubMed ID: 9279969
[TBL] [Abstract][Full Text] [Related]
13. Impact of prehypertension on common carotid artery intima-media thickness and left ventricular mass.
Manios E; Tsivgoulis G; Koroboki E; Stamatelopoulos K; Papamichael C; Toumanidis S; Stamboulis E; Vemmos K; Zakopoulos N
Stroke; 2009 Apr; 40(4):1515-8. PubMed ID: 19164793
[TBL] [Abstract][Full Text] [Related]
14. Carotid intima-media thickness and plaque volume changes following 2-year angiotensin II-receptor blockade. The Multicentre Olmesartan atherosclerosis Regression Evaluation (MORE) study.
Stumpe KO; Agabiti-Rosei E; Zielinski T; Schremmer D; Scholze J; Laeis P; Schwandt P; Ludwig M;
Ther Adv Cardiovasc Dis; 2007 Dec; 1(2):97-106. PubMed ID: 19124398
[TBL] [Abstract][Full Text] [Related]
15. Impact of amlodipine or ramipril treatment on left ventricular mass and carotid intima-media thickness in nondiabetic hemodialysis patients.
Yilmaz R; Altun B; Kahraman S; Ozer N; Akinci D; Turgan C
Ren Fail; 2010; 32(8):903-12. PubMed ID: 20722555
[TBL] [Abstract][Full Text] [Related]
16. Tissue velocity echocardiography shows early improvement in diastolic function with irbesartan and atenolol therapy in patients with hypertensive left ventricular hypertrophy. Results form the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA).
Müller-Brunotte R; Kahan T; Malmqvist K; Ring M; Edner M
Am J Hypertens; 2006 Sep; 19(9):927-36. PubMed ID: 16942935
[TBL] [Abstract][Full Text] [Related]
17. Effects of doxazosin in the gastrointestinal therapeutic system formulation versus doxazosin standard and placebo in mild-to-moderate hypertension. Doxazosin Investigators' Study Group.
Os I; Stokke HP
J Cardiovasc Pharmacol; 1999 May; 33(5):791-7. PubMed ID: 10226868
[TBL] [Abstract][Full Text] [Related]
18. Change of left ventricular geometric pattern after 1 year of antihypertensive treatment: the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study.
Wachtell K; Dahlöf B; Rokkedal J; Papademetriou V; Nieminen MS; Smith G; Gerdts E; Boman K; Bella JN; Devereux RB
Am Heart J; 2002 Dec; 144(6):1057-64. PubMed ID: 12486431
[TBL] [Abstract][Full Text] [Related]
19. Absence of detectable regression of human hypertensive left ventricular hypertrophy following drug treatment for 1 year.
Laufer E; Reid C; Qi XL; Jennings GL
Clin Exp Pharmacol Physiol; 1998; 25(3-4):208-15. PubMed ID: 9590570
[TBL] [Abstract][Full Text] [Related]
20. Candesartan- and atenolol-based treatments induce different patterns of carotid artery and left ventricular remodeling in hypertension.
Ariff B; Zambanini A; Vamadeva S; Barratt D; Xu Y; Sever P; Stanton A; Hughes A; Thom S
Stroke; 2006 Sep; 37(9):2381-4. PubMed ID: 16888272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
